FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295959997> ?p ?o ?g. }

• W4295959997 endingPage "154123" @default.
• W4295959997 startingPage "154123" @default.
• W4295959997 abstract "Pancreatic secretory granule membrane major glycoprotein 2 (GP2) is a membrane component of zymogen granules which is abundantly secreted by pancreatic acinar cells. Because RNA based analyses suggest a strict limitation of GP2 expression to the pancreas in normal tissues, and a strong preference to pancreatic cancer among tumors, GP2 expression analysis might have diagnostic utility. To better understand the role of GP2 protein expression, GP2 was successfully analyzed in 27,965 tumor samples from 132 different tumor types and subtypes as well as 8 samples each of 76 different normal tissue types by immunohistochemistry in a tissue microarray format (TMA). GP2 immunostaining was seen in 14 of 16 (87.5 %) acinar cell carcinomas, 6 of 507 (1.2 %) ductal adenocarcinomas, and 3 of 99 neuroendocrine neoplasms of the pancreas (3.0 %). GP2 was also found in 23 extra-pancreatic tumor entities including several types of neuroendocrine neoplasms (14.3-58.8 %), prostatic adenocarcinomas (8.2-18.8 %), various other adenocarcinomas (0.1-7.7 %), and several categories of benign and malignant salivary gland tumors (2.3-3.1 %). A strong GP2 positivity was only seen in 6 tumor categories including 50 % of 16 pancreatic acinus cell carcinomas, 11.8 % of 17 neuroendocrine tumors of the lung, 1.3 % of 80 primary Gleason 4 + 4 % and 0.6 % of 181 recurrent prostate cancers, as well as 0.8 % of 133 adenocarcinomas of the lung. In a cohort of 14,747 prostate cancers with follow up data, GP2 immunostaining was strongly linked to advanced pT stage, high Gleason grade, lymph node metastasis, and recurrence free survival (p < 0.0001 each). The prognostic impact of GP2 positivity was independent of established parameters in TMPRSS2:ERG fusion-negative cancers (p < 0.0001). In summary, our data show that GP2 is preferentially expressed in acinar cell carcinomas of the pancreas but the glycoprotein can - rarely - also be expressed in a variety of other tumor entities." @default.
• W4295959997 created "2022-09-16" @default.
• W4295959997 creator A5007249612 @default.
• W4295959997 creator A5008273506 @default.
• W4295959997 creator A5013928422 @default.
• W4295959997 creator A5024548324 @default.
• W4295959997 creator A5034204447 @default.
• W4295959997 creator A5035525469 @default.
• W4295959997 creator A5036792324 @default.
• W4295959997 creator A5037064914 @default.
• W4295959997 creator A5039238330 @default.
• W4295959997 creator A5039983309 @default.
• W4295959997 creator A5049914905 @default.
• W4295959997 creator A5053478291 @default.
• W4295959997 creator A5058620855 @default.
• W4295959997 creator A5060519896 @default.
• W4295959997 creator A5062979282 @default.
• W4295959997 creator A5063439508 @default.
• W4295959997 creator A5065312050 @default.
• W4295959997 creator A5068056508 @default.
• W4295959997 creator A5071506845 @default.
• W4295959997 creator A5072526716 @default.
• W4295959997 creator A5079884607 @default.
• W4295959997 creator A5083166298 @default.
• W4295959997 creator A5086499788 @default.
• W4295959997 creator A5087301838 @default.
• W4295959997 creator A5090488652 @default.
• W4295959997 date "2022-10-01" @default.
• W4295959997 modified "2023-09-27" @default.
• W4295959997 title "Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors" @default.
• W4295959997 cites W1481407129 @default.
• W4295959997 cites W1969557485 @default.
• W4295959997 cites W2001712372 @default.
• W4295959997 cites W2003686201 @default.
• W4295959997 cites W2018211058 @default.
• W4295959997 cites W2018838463 @default.
• W4295959997 cites W2054267783 @default.
• W4295959997 cites W2080095406 @default.
• W4295959997 cites W2087810003 @default.
• W4295959997 cites W2089902163 @default.
• W4295959997 cites W2108797218 @default.
• W4295959997 cites W2118170988 @default.
• W4295959997 cites W2126774108 @default.
• W4295959997 cites W2165098240 @default.
• W4295959997 cites W2467158996 @default.
• W4295959997 cites W2507306980 @default.
• W4295959997 cites W2565295279 @default.
• W4295959997 cites W2613629789 @default.
• W4295959997 cites W2789556762 @default.
• W4295959997 cites W2899971546 @default.
• W4295959997 cites W3037894338 @default.
• W4295959997 cites W3096947280 @default.
• W4295959997 cites W3129786277 @default.
• W4295959997 cites W4226215075 @default.
• W4295959997 cites W4252728309 @default.
• W4295959997 doi "https://doi.org/10.1016/j.prp.2022.154123" @default.
• W4295959997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36137400" @default.
• W4295959997 hasPublicationYear "2022" @default.
• W4295959997 type Work @default.
• W4295959997 citedByCount "0" @default.
• W4295959997 crossrefType "journal-article" @default.
• W4295959997 hasAuthorship W4295959997A5007249612 @default.
• W4295959997 hasAuthorship W4295959997A5008273506 @default.
• W4295959997 hasAuthorship W4295959997A5013928422 @default.
• W4295959997 hasAuthorship W4295959997A5024548324 @default.
• W4295959997 hasAuthorship W4295959997A5034204447 @default.
• W4295959997 hasAuthorship W4295959997A5035525469 @default.
• W4295959997 hasAuthorship W4295959997A5036792324 @default.
• W4295959997 hasAuthorship W4295959997A5037064914 @default.
• W4295959997 hasAuthorship W4295959997A5039238330 @default.
• W4295959997 hasAuthorship W4295959997A5039983309 @default.
• W4295959997 hasAuthorship W4295959997A5049914905 @default.
• W4295959997 hasAuthorship W4295959997A5053478291 @default.
• W4295959997 hasAuthorship W4295959997A5058620855 @default.
• W4295959997 hasAuthorship W4295959997A5060519896 @default.
• W4295959997 hasAuthorship W4295959997A5062979282 @default.
• W4295959997 hasAuthorship W4295959997A5063439508 @default.
• W4295959997 hasAuthorship W4295959997A5065312050 @default.
• W4295959997 hasAuthorship W4295959997A5068056508 @default.
• W4295959997 hasAuthorship W4295959997A5071506845 @default.
• W4295959997 hasAuthorship W4295959997A5072526716 @default.
• W4295959997 hasAuthorship W4295959997A5079884607 @default.
• W4295959997 hasAuthorship W4295959997A5083166298 @default.
• W4295959997 hasAuthorship W4295959997A5086499788 @default.
• W4295959997 hasAuthorship W4295959997A5087301838 @default.
• W4295959997 hasAuthorship W4295959997A5090488652 @default.
• W4295959997 hasConcept C121608353 @default.
• W4295959997 hasConcept C126322002 @default.
• W4295959997 hasConcept C142724271 @default.
• W4295959997 hasConcept C193270364 @default.
• W4295959997 hasConcept C204232928 @default.
• W4295959997 hasConcept C2776235491 @default.
• W4295959997 hasConcept C2777714996 @default.
• W4295959997 hasConcept C2778764654 @default.
• W4295959997 hasConcept C2780210213 @default.
• W4295959997 hasConcept C2781182431 @default.
• W4295959997 hasConcept C4224716 @default.
• W4295959997 hasConcept C71924100 @default.

• next